INTER-INSTITUTE PROGRAM FOR THE DEVELOPMENT OF AIDS-RELATED THERAPEUTICS
RELEASE DATE: April 7, 2004
NOTICE: NOT-AI-04-024
National Institute of Allergy and Infectious Diseases (NIAID)
(http://www.niaid.nih.gov/)
National Cancer Institute (NCI)
(http://www.nci.nih.gov)
LETTER OF INTENT RECEIPT DATE: May 1, 2004
APPLICATION RECEIPT DATE: June 1, 2004
The Inter-Institute Program for the Development of AIDS-Related
Therapeutics (IIP) is co-sponsored by The National Institute of Allergy
and Infectious Diseases (NIAID) and National Cancer Institute (NCI).
Investigators are invited to submit proposals to this therapeutics
development program. IIP is designed to help AIDS research investigators
facilitate the pre-clinical development of: 1) therapies for the treatment
of HIV disease, AIDS-associated malignancies, opportunistic infections and
tuberculosis associated with AIDS, and 2) microbicide-based prevention
strategies for HIV. IIP does NOT fund grants. Instead, applications to
the program are requests to use IIP drug development resources to conduct
specific tasks the applicants themselves are unable to carry out in their
efforts to translate basic research findings to applied or clinical
practice. Examples of tasks that may be requested include High Throughput
Screen (HTS) assay development, evaluation in animal efficacy models, Good
Manufacturing Practice (GMP) scale-up synthesis of small molecules and
biologics, clinical dosage formulation and manufacturing, and Good
Laboratory Practice (GLP) toxicology. Program proposals are solicited
twice per year on June 1 and December 1 and reviewed in a competitive
manner.
The current deadline for receipt of applications is June 1, 2004; prior to
that date (no later than May 1, 2004) a Letter of Intent must be submitted
to the Inter-Institute Program Coordinator. Further information about
this program, including detailed instructions for preparing proposals and
the Letter of Intent, can be found at the program web site at
http://dtp.nci.nih.gov/docs/dart.html.
INQUIRIES
Inter-Institute Program Coordinator
6130 Executive Boulevard, Suite 8022
Rockville, MD 20852
Telephone: (301) 496-8720
FAX : (301) 402-0831
E-mail: [email protected]
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
| ||||||
|
|
Department of Health and Human Services (HHS) |
|
||||
|
NIH... Turning Discovery Into Health® |
||||||